Literature DB >> 17085073

p11 (S100A10)--an inducible adaptor protein that modulates neuronal functions.

Per Svenningsson1, Paul Greengard.   

Abstract

p11 (S100A10) is a member of the S100 protein family and forms a heterotetrameric complex with annexin 2. p11 has also been found to interact with a diverse set of proteins that includes several ion channels and the serotonin 5-HT1B receptor. Several factors such as dexamethasone, growth factors, nitric oxide and antidepressant therapies regulate the expression of p11. Furthermore, studies using mutant mouse models, RNA interference and antisense constructs have implicated p11 in several biological processes; in particular, there is evidence that p11 is involved in the pathophysiology underlying nociception and depression-like states.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085073     DOI: 10.1016/j.coph.2006.10.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  43 in total

Review 1.  Neurological effects of blast injury.

Authors:  Ramona R Hicks; Stephanie J Fertig; Rebecca E Desrocher; Walter J Koroshetz; Joseph J Pancrazio
Journal:  J Trauma       Date:  2010-05

2.  Alteration by p11 of mGluR5 localization regulates depression-like behaviors.

Authors:  K-W Lee; L Westin; J Kim; J C Chang; Y-S Oh; B Amreen; J Gresack; M Flajolet; D Kim; A Aperia; Y Kim; P Greengard
Journal:  Mol Psychiatry       Date:  2015-09-15       Impact factor: 15.992

3.  Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.

Authors:  Roberta Marongiu; Margarita Arango-Lievano; Veronica Francardo; Peter Morgenstern; Xiaoqun Zhang; M Angela Cenci; Per Svenningsson; Paul Greengard; Michael G Kaplitt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

4.  Treating the brain deep down: Short-circuiting depression.

Authors:  Jennifer Warner-Schmidt
Journal:  Nat Med       Date:  2013-06       Impact factor: 53.440

Review 5.  The annexin A2 system and vascular homeostasis.

Authors:  Elle C Flood; Katherine A Hajjar
Journal:  Vascul Pharmacol       Date:  2011-03-29       Impact factor: 5.773

Review 6.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 7.  The role of protein-protein interactions in the intracellular traffic of the potassium channels TASK-1 and TASK-3.

Authors:  Markus Kilisch; Olga Lytovchenko; Blanche Schwappach; Vijay Renigunta; Jürgen Daut
Journal:  Pflugers Arch       Date:  2015-01-07       Impact factor: 3.657

8.  Development of a novel DsRed-NLS vector with a monopartite classical nuclear localization signal.

Authors:  Hee Sang You; Yeon Jeong Ok; Eun Jeong Lee; Sang Sun Kang; Sung Hee Hyun
Journal:  3 Biotech       Date:  2019-05-24       Impact factor: 2.406

Review 9.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

10.  Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs.

Authors:  L Perez-Caballero; R Pérez-Egea; C Romero-Grimaldi; D Puigdemont; J Molet; J-R Caso; J-A Mico; V Pérez; J-C Leza; E Berrocoso
Journal:  Mol Psychiatry       Date:  2013-05-28       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.